Comparison of patient, hospitalization and center characteristics from the EMMY centers, IFM centers, and all multiple myeloma centers in France [0.03%]
来自法国EMMY中心、IFM中心和所有多发性骨髓瘤中心的患者、住院和中心特征比较
Decaux Olivier,Ronan Garlantezec,Aurore Perrot et al.
Decaux Olivier et al.
Background: Multiple myeloma (MM) is an incurable hematological malignancy with increasing prevalence. While randomized controlled trials have demonstrated survival improvements, they underrepresent older and comorbid pat...
Allogeneic hematopoietic stem cell transplantation for VEXAS syndrome: A review and a case report [0.03%]
VEXAS综合征异基因造血干细胞移植的文献回顾及1例报告
Kentaro Nagae,Hiroyuki Muranushi,Yasuhito Nannya et al.
Kentaro Nagae et al.
Background: VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is caused by somatic UBA1 mutations and frequently complicated by myelodysplastic syndrome (MDS). Conventional immunosuppressive and an...
Alicia Shin,Kian Rahbari,Wichai Chinratanalab et al.
Alicia Shin et al.
Bladder mass following bone marrow transplant for sickle cell disease: A diagnostic dilemma [0.03%]
接受骨髓移植治疗镰状细胞病后发生的膀胱肿物：一个诊断上的难题
Yusuf Adelabu,Ugonna O Fakile,Wale Q Oladimeji et al.
Yusuf Adelabu et al.
Hematuria is a common sign of kidney and urinary tract issues in sickle cell disease (SCD). Hematopoietic stem cell transplantation (HSCT) can cure SCD but may also be complicated by conditions that cause hematuria. We report a case of pain...
Guidelines and consensus for minimal residual disease-adapted therapy in multiple myeloma from the Pan-Pacific multiple myeloma working group [0.03%]
泛亚多发性骨髓瘤工作组有关微小残留病指导和共识的适应性治疗意见书
Wenming Chen,Zhen Cai,Chor Sang Chim et al.
Wenming Chen et al.
Treatment of multiple myeloma (MM) has entered the era of deep remission-oriented therapy, where minimal residual disease (MRD) has become a key indicator for treatment response and long-term prognosis, surpassing conventional complete remi...
Should monitoring guidelines and decision to treat for IgM MGUS be different when caring for Jehovah's Witness patients? [0.03%]
应如何看待耶和华见证人系统性免疫球蛋白M单克隆 gammopathy of undetermined significance患者的监测指南及治疗决策？
Marshall Rosenberg,Alisha P Maity,Karthik Shankar et al.
Marshall Rosenberg et al.
A practicing Jehovah's Witness with diagnosed IgM monoclonal gammopathy of undetermined significance (MGUS) in 2014 was hospitalized within one year of her annual checkup. She had hyperviscosity syndrome with blurry vision and severe anemia...
Disseminated adenovirus infection following CAR T-cell therapy: Early-onset presentation in a patient with relapsed refractory mantle cell lymphoma [0.03%]
靶向CAR-T细胞治疗后的广泛性腺病毒感然：在复发及药物耐受的套细胞淋巴瘤患者中的早期临床表现案例研究
Anusha Gopalam,Noha Soror,Aqsa Ashraf et al.
Anusha Gopalam et al.
Leukemia cutis and all-trans retinoic acid-induced myocarditis in acute promyelocytic leukemia [0.03%]
皮肤粒细胞性白血病和全反式维甲酸诱导的心肌炎在急性早幼粒细胞白血病中的发生
Kian J Rahbari,Parth C Patel,Sarah Profitt et al.
Kian J Rahbari et al.
Acute promyelocytic leukemia (APL) is frequently curable in the modern era using the chemotherapy-free regimen of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). However, rare disease manifestations and treatment complications ma...
Co-occurrence of angioimmunoblastic T-cell lymphoma and aggressive-refractory plasma-cell neoplasm: Two new cases and literature review [0.03%]
血管免疫母细胞性T细胞淋巴瘤伴发浆细胞肿瘤两例及文献复习
M Christina Cox,Claudia Seimonte,Erica Giacobbi et al.
M Christina Cox et al.
Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive peripheral T-cell lymphoma of T-follicular helper (TFH) cell origin, characterized by systemic manifestations, immune dysregulation, and frequent secondary B-cell proliferat...
Chronic graft versus host disease in upper limb: Calling upper limb rehabilitation specialists for improving outcomes in patients [0.03%]
慢性移植物抗宿主病致上肢残疾：呼唤上肢康复医师改善患者预后
Jaleel A Mohammed,Caroline Couthard,Ahmed AlGhamdi et al.
Jaleel A Mohammed et al.
Background: Chronic graft versus host disease (cGVHD) is a complex post-transplant complication resulting in varying degrees of musculoskeletal (MSK) manifestations, including sclerosis-type skin conditions, fasciitis, an...